Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- RPHM
- Price
- -
- Stock movement up
- +0.90 (5.20%)
- Company name
- Reneo Pharmaceuticals Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 60.84M
- Ent value
- 26.72M
- Price/Sales
- 41.44
- Price/Book
- 0.79
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -75.24%
- 3 year return
- -36.80%
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
RPHM does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 41.44 |
| Price to Book | 0.79 |
| EV to Sales | 18.20 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 3.34M |
| EPS (TTM) | -1.69 |
| FCF per share (TTM) | -1.99 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.47M |
| Gross profit (TTM) | 619.00K |
| Operating income (TTM) | -62.88M |
| Net income (TTM) | -56.54M |
| EPS (TTM) | -1.69 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 42.17% |
| Operating margin (TTM) | -4283.65% |
| Profit margin (TTM) | -3851.29% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 35.97M |
| Net receivables | 0.00 |
| Total current assets | 77.99M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 574.00K |
| Total assets | 78.72M |
| Accounts payable | 64.00K |
| Short/Current long term debt | 823.00K |
| Total current liabilities | 1.35M |
| Total liabilities | 1.85M |
| Shareholder's equity | 76.87M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -66.34M |
| Capital expenditures (TTM) | 71.00K |
| Free cash flow (TTM) | -66.39M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -73.55% |
| Return on Assets | -71.82% |
| Return on Invested Capital | -73.23% |
| Cash Return on Invested Capital | -85.99% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| RPHM | S&P500 | |
| Current price drop from All-time high | -87.81% | -0.14% |
| Highest price drop | -91.23% | -56.47% |
| Date of highest drop | 13 Sep 2024 | 9 Mar 2009 |
| Avg drop from high | -66.48% | -11.07% |
| Avg time to new high | 126 days | 12 days |
| Max time to new high | 859 days | 1805 days |
COMPANY DETAILS
Marketcap
60.84M
Marketcap category
Small-cap
Description
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company's lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.
Employees
8
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner